China News Service, March 1, According to a report from Reuters on March 1, a senior official in the Biden administration revealed that Johnson & Johnson may begin supplying the new crown vaccine in the United States on March 2.
At the same time, as three vaccines have been approved for emergency use in the United States, the authorities hope to increase the COVID-19 vaccination rate among minorities.
On February 16, local time, the mass vaccination station set up at Oakland Stadium, California, was opened to eligible people.
According to reports, officials admitted that, according to relevant data, the vaccination rate among minority groups such as African Americans is much lower than that of white groups.
For example, in Alabama, blacks account for 27% of the population and 31% of the total deaths from the new crown, but only 17% of vaccinations.
Officials said that the US government will continue to track vaccine supply to ensure that the vaccine is evenly distributed among different populations.
According to the report, the difference from the Modena vaccine and the vaccines of Pfizer and BioNTech is that the Johnson & Johnson vaccine is a single-dose vaccine that can be immune to the new coronavirus after one injection.
In addition, Johnson & Johnson vaccine can be stored and transported at refrigerator temperature, making it easier to distribute.
The US Food and Drug Administration (FDA) officially approved the emergency use authorization of Johnson & Johnson's new crown vaccine on February 27, making Johnson & Johnson vaccine the third new crown vaccine approved in the United States.